Skip to content
About Us
Science
Team
Media
Investors
Contact
About Us
Science
Team
Media
Investors
Contact
News
August 5, 2026
Expedition CEO Yi Larson Says $115 Million Series B is ‘Defining Milestone’
< Prev
Expedition Therapeutics Announces Oversubscribed $115 Million Series B Financing to Advance Next-Generation DPP1 Inhibitor for COPD
Next >